1. Home
  2. DOGZ vs TOVX Comparison

DOGZ vs TOVX Comparison

Compare DOGZ & TOVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dogness (International) Corporation

DOGZ

Dogness (International) Corporation

N/A

Current Price

$0.46

Market Cap

10.6M

ML Signal

N/A

Logo Theriva Biologics Inc.

TOVX

Theriva Biologics Inc.

N/A

Current Price

$0.16

Market Cap

11.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DOGZ
TOVX
Founded
2003
2001
Country
China
United States
Employees
N/A
N/A
Industry
Miscellaneous manufacturing industries
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
10.6M
11.1M
IPO Year
2017
2012

Fundamental Metrics

Financial Performance
Metric
DOGZ
TOVX
Price
$0.46
$0.16
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
★ $2.50
AVG Volume (30 Days)
22.4K
★ 1.0M
Earning Date
09-30-2026
08-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 89.07
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.14
52 Week High
$13.00
$0.49

Technical Indicators

Market Signals
Indicator
DOGZ
TOVX
Relative Strength Index (RSI) 18.61 29.84
Support Level N/A N/A
Resistance Level $1.41 $0.25
Average True Range (ATR) 0.08 0.02
MACD -0.02 -0.00
Stochastic Oscillator 32.29 29.78

Price Performance

Historical Comparison
DOGZ
TOVX

About DOGZ Dogness (International) Corporation

Dogness (International) Corp designs, manufactures pet products, including leashes and smart products, and lanyards. The company designs, processes, and manufactures fashionable and high-quality leashes, collars, and harnesses to complement cats and dogs appearances, as well as intelligent pet products. The company also provides dyeing services to external customers, as well as pet grooming services. The dyeing service is to utilize the existing production capacity and the pet grooming service is immaterial. Geographically, it generates maximum revenue from Europe and also has a presence in the Mainland China, United States, Europe, Australia, Canada, Central, and South America, Japan, and other Asian countries and regions.

About TOVX Theriva Biologics Inc.

Theriva Biologics Inc is a clinical-stage pharmaceutical company developing a novel oncolytic adenovirus (OV) platform to address devastating cancers with high unmet needs. It is a clinical-stage program VCN-01, designed to break down the tumor stroma, and its preclinical-stage program VCN-11 leverages its proprietary Albumin Shield Technology to protect systemically administered oncolytic viruses from the host immune system. Product Candidates includes SYN-004 (ribaxamase) and SYN-020.

Share on Social Networks: